ChemoMetec A/S (DE:CHY)
FRANKFURT:CHY
CHY Stock Chart & Stats
€86.25
€0.10(0.14%)
At close: 4:00 PM EST
€86.25
€0.10(0.14%)
Day’s Range― - ―
52-Week Range€33.74 - €106.60
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€876.29M
Enterprise ValueN/A
Total Cash (Recent Filing)€264.74M
Total Debt (Recent Filing)€7.78M
Price to Earnings (P/E)36.8
Beta0.67
Next Earnings
Sep 10, 2026EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.72
Shares Outstanding17,402,480
10 Day Avg. Volume0
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€70.23Price Target Upside-18.57% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ChemoMetec A/S News
CHY FAQ
What was ChemoMetec A/S’s price range in the past 12 months?
ChemoMetec A/S lowest stock price was €33.74 and its highest was €106.60 in the past 12 months.
What is ChemoMetec A/S’s market cap?
ChemoMetec A/S’s market cap is €876.29M.
When is ChemoMetec A/S’s upcoming earnings report date?
ChemoMetec A/S’s upcoming earnings report date is Sep 10, 2026 which is in 88 days.
How were ChemoMetec A/S’s earnings last quarter?
ChemoMetec A/S released its earnings results on Apr 30, 2026. The company reported €0.649 earnings per share for the quarter, beating the consensus estimate of €0.49 by €0.159.
Is ChemoMetec A/S overvalued?
According to Wall Street analysts ChemoMetec A/S’s price is currently Overvalued.
Does ChemoMetec A/S pay dividends?
ChemoMetec A/S does not currently pay dividends.
What is ChemoMetec A/S’s EPS estimate?
ChemoMetec A/S’s EPS estimate is -0.15.
How many shares outstanding does ChemoMetec A/S have?
ChemoMetec A/S has 17,402,480 shares outstanding.
What happened to ChemoMetec A/S’s price movement after its last earnings report?
ChemoMetec A/S reported an EPS of €0.649 in its last earnings report, beating expectations of €0.49. Following the earnings report the stock price went down -0.855%.
Which hedge fund is a major shareholder of ChemoMetec A/S?
Currently, no hedge funds are holding shares in DE:CHY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ChemoMetec A/S
Headquartered in Allerød, Denmark, and established in 1997, ChemoMetec A/S focuses on the design, production, and worldwide distribution of analytical instruments for cell enumeration and analysis. Their sophisticated solutions are utilized across diverse fields, including cell-based therapeutics, oncology and stem cell research, pharmaceutical development and manufacturing, along with quality assurance for animal semen and beer. The company's product offerings feature a range of NucleoCounter devices, such as the NC-3000 advanced image cytometer, the NC-250 automated cell analyzer, and the consistent NC-202 and NC-200 automated cell counters for viability assessment. Specialized counters include the NucleoCounter SP-100 for automated sperm cell analysis in animal production, the SCC-100 for measuring somatic cells in milk samples, and the YC-100 for total count and viability of yeast cells. Beyond equipment, they also supply vital consumables like cassettes and reagents, various accessories such as software and cables, and offer extensive service and validation plans.
CHY Stock 12 Month Forecast
Average Price Target
€70.23
▼(-18.57% Downside)
Technical Analysis
Options Prices
Currently, No data available
---